Glassia is a prescription medication used to treat alpha-1 antitrypsin deficiency, a genetic disorder that can lead to lung and liver problems. This medication contains a purified form of the alpha-1 protein, which helps to protect the lungs and liver from damage caused by inflammation.

Glassia is administered through intravenous infusion, typically once a week. It is important to follow the dosing schedule provided by your healthcare provider to ensure the best results. Your healthcare provider will determine the appropriate dosage based on your individual needs and response to treatment.

Common side effects of Glassia may include headache, dizziness, nausea, and injection site reactions. It is important to report any unusual or severe side effects to your healthcare provider promptly.

It is important to inform your healthcare provider about any other medications or supplements you are taking before starting Glassia, as they may interact with this medication. Additionally, it is important to inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before starting Glassia.

Overall, Glassia can be an effective treatment option for individuals with alpha-1 antitrypsin deficiency. It is important to work closely with your healthcare provider to monitor your progress and adjust your treatment plan as needed. If you have any questions or concerns about Glassia, do not hesitate to discuss them with your healthcare provider.